tiprankstipranks
Trending News
More News >
Cybin (TSE:CYBN)
NEO-L:CYBN
Canadian Market

Cybin (CYBN) Stock Forecast & Price Target

Compare
479 Followers
See the Price Targets and Ratings of:

CYBN Analyst Ratings

Strong Buy
5Ratings
Strong Buy
5 Buy
0 Hold
0 Sell
Based on 5 analysts giving stock ratings to
Cybin
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

CYBN Stock 12 Month Forecast

Average Price Target

C$127.16
▲(90732.06%Upside)
Based on 5 Wall Street analysts offering 12 month price targets for Cybin in the last 3 months. The average price target is C$127.16 with a high forecast of C$205.10 and a low forecast of C$34.18. The average price target represents a 90732.06% change from the last price of C$0.14.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"206":"C$206","-1":"-C$1","50.75":"C$50.8","102.5":"C$102.5","154.25":"C$154.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":205.104645,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$205.10</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":127.1648799,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$127.16</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":34.1841075,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$34.18</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,50.75,102.5,154.25,206],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"May<br/>2024","6":"Nov<br/>2024","9":"Mar<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.135,15.90189576923077,31.66879153846154,47.435687307692305,63.20258307692308,78.96947884615385,94.73637461538462,110.50327038461539,126.27016615384616,142.03706192307692,157.80395769230768,173.57085346153846,189.33774923076922,{"y":205.104645,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.135,9.906529223076923,19.678058446153848,29.44958766923077,39.22111689230769,48.992646115384616,58.764175338461534,68.53570456153847,78.30723378461539,88.07876300769232,97.85029223076924,107.62182145384617,117.39335067692308,{"y":127.1648799,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.135,2.7541621153846156,5.3733242307692315,7.992486346153847,10.611648461538463,13.230810576923078,15.849972692307695,18.469134807692313,21.08829692307693,23.707459038461543,26.32662115384616,28.945783269230777,31.564945384615392,{"y":34.1841075,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.135,"date":1706745600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1709251200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1711929600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":0.135,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetC$205.10Average Price TargetC$127.16Lowest Price TargetC$34.18
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on TSE:CYBN
Sumant KulkarniCanaccord Genuity
Canaccord Genuity
C$99.82C$95.72
Buy
68268.21%
Upside
Reiterated
07/07/25
Cybin's Promising Clinical Progress and Strong Financial Position Justify Buy Rating
H.C. Wainwright Analyst forecast on TSE:CYBN
Patrick TrucchioH.C. Wainwright
H.C. Wainwright
C$205.1
Buy
146403.32%
Upside
Reiterated
07/03/25
Cybin's Strong Position in Psychedelic Neuropsychiatry: Buy Rating Backed by Advancements and Financial Flexibility
Alliance Global Partners Analyst forecast on TSE:CYBN
James MolloyAlliance Global Partners
Alliance Global Partners
C$34.18
Buy
24317.22%
Upside
Reiterated
07/02/25
Analysts Are Bullish on Top Healthcare Stocks: Centene (CNC), Cybin (CYBN)
Bloom Burton Analyst forecast on TSE:CYBN
David Martin PhDBloom Burton
Bloom Burton
C$155.88
Buy
111242.52%
Upside
Reiterated
06/24/25
Wall Street Analysts Are Bullish on Top Healthcare Picks
Lucid Capital Analyst forecast on TSE:CYBN
Elemer PirosLucid Capital
Lucid Capital
C$144.94
Buy
103429.01%
Upside
Initiated
06/06/25
Cybin initiated with a Buy at Lucid CapitalCybin initiated with a Buy at Lucid Capital
Guggenheim Analyst forecast on TSE:CYBN
Eddie HickmanGuggenheim
Guggenheim
C$47.86
Buy
34084.11%
Upside
Initiated
03/12/25
Cybin wins new Buy from Guggenheim: potential to challenge JJs Spravato citedGuggenheim has initiated its coverage of psychedelic drug developer Cybin ( NYSE:CYBN ) with a Buy rating and a $35 per share target, indicating that the companys lead asset, CYB003, can one-day rival JJs (JNJ) FDA-approved depression therapy Spravato.
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Canaccord Genuity Analyst forecast on TSE:CYBN
Sumant KulkarniCanaccord Genuity
Canaccord Genuity
C$99.82C$95.72
Buy
68268.21%
Upside
Reiterated
07/07/25
Cybin's Promising Clinical Progress and Strong Financial Position Justify Buy Rating
H.C. Wainwright Analyst forecast on TSE:CYBN
Patrick TrucchioH.C. Wainwright
H.C. Wainwright
C$205.1
Buy
146403.32%
Upside
Reiterated
07/03/25
Cybin's Strong Position in Psychedelic Neuropsychiatry: Buy Rating Backed by Advancements and Financial Flexibility
Alliance Global Partners Analyst forecast on TSE:CYBN
James MolloyAlliance Global Partners
Alliance Global Partners
C$34.18
Buy
24317.22%
Upside
Reiterated
07/02/25
Analysts Are Bullish on Top Healthcare Stocks: Centene (CNC), Cybin (CYBN)
Bloom Burton Analyst forecast on TSE:CYBN
David Martin PhDBloom Burton
Bloom Burton
C$155.88
Buy
111242.52%
Upside
Reiterated
06/24/25
Wall Street Analysts Are Bullish on Top Healthcare Picks
Lucid Capital Analyst forecast on TSE:CYBN
Elemer PirosLucid Capital
Lucid Capital
C$144.94
Buy
103429.01%
Upside
Initiated
06/06/25
Cybin initiated with a Buy at Lucid CapitalCybin initiated with a Buy at Lucid Capital
Guggenheim Analyst forecast on TSE:CYBN
Eddie HickmanGuggenheim
Guggenheim
C$47.86
Buy
34084.11%
Upside
Initiated
03/12/25
Cybin wins new Buy from Guggenheim: potential to challenge JJs Spravato citedGuggenheim has initiated its coverage of psychedelic drug developer Cybin ( NYSE:CYBN ) with a Buy rating and a $35 per share target, indicating that the companys lead asset, CYB003, can one-day rival JJs (JNJ) FDA-approved depression therapy Spravato.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Cybin

1 Month
xxx
Success Rate
5/14 ratings generated profit
36%
Average Return
-4.44%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 1 Month would result in 35.71% of your transactions generating a profit, with an average return of -4.44% per trade.
3 Months
xxx
Success Rate
7/14 ratings generated profit
50%
Average Return
+2.91%
reiterated a xxx
rating 5 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 3 Months would result in 50.00% of your transactions generating a profit, with an average return of +2.91% per trade.
1 Year
Patrick TrucchioH.C. Wainwright
Success Rate
3/22 ratings generated profit
14%
Average Return
-25.44%
reiterated a buy rating 9 days ago
Copying Patrick Trucchio's trades and holding each position for 1 Year would result in 13.64% of your transactions generating a profit, with an average return of -25.44% per trade.
2 Years
xxx
Success Rate
1/22 ratings generated profit
5%
Average Return
-36.90%
reiterated a xxx
rating 9 days ago
Copying xxxxxxxxxxxxxxxxxx
trades and holding each position for 2 Years would result in 4.55% of your transactions generating a profit, with an average return of -36.90% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CYBN Analyst Recommendation Trends

Rating
Feb 25
Mar 25
May 25
Jun 25
Jul 25
Strong Buy
11
6
6
4
6
Buy
0
0
0
0
0
Hold
0
0
0
0
0
Sell
0
0
0
0
0
Strong Sell
0
0
0
0
0
total
11
6
6
4
6
In the current month, CYBN has received 6 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. CYBN average Analyst price target in the past 3 months is 127.16.
Each month's total comprises the sum of three months' worth of ratings.

CYBN Financial Forecast

CYBN Earnings Forecast

The previous quarter’s earnings for CYBN were -C$1.46.
The previous quarter’s earnings for CYBN were -C$1.46.
No data currently available

CYBN Sales Forecast

The previous quarter’s earnings for CYBN were C$0.00.
The previous quarter’s earnings for CYBN were C$0.00.

CYBN Stock Forecast FAQ

What is TSE:CYBN’s average 12-month price target, according to analysts?
Based on analyst ratings, Cybin’s 12-month average price target is 127.16.
    What is TSE:CYBN’s upside potential, based on the analysts’ average price target?
    Cybin has 90732.06% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is TSE:CYBN a Buy, Sell or Hold?
          Cybin has a consensus rating of Strong Buy which is based on 5 buy ratings, 0 hold ratings and 0 sell ratings.
            What is Cybin’s price target?
            The average price target for Cybin is 127.16. This is based on 5 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst price target is C$205.10 ,the lowest forecast is C$34.18. The average price target represents 90732.06% Increase from the current price of C$0.14.
              What do analysts say about Cybin?
              Cybin’s analyst rating consensus is a Strong Buy. This is based on the ratings of 5 Wall Streets Analysts.
                How can I buy shares of TSE:CYBN?
                Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis